Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Short term Debt (2022)

Historic Short term Debt for Mereo BioPharma (MREO) over the last 1 years, with Q4 2022 value amounting to $486000.0.

  • Mereo BioPharma's Short term Debt changed N/A to $486000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $486000.0, marking a year-over-year change of. This contributed to the annual value of $486000.0 for FY2022, which is N/A changed from last year.
  • As of Q4 2022, Mereo BioPharma's Short term Debt stood at $486000.0.
  • Over the past 5 years, Mereo BioPharma's Short term Debt peaked at $486000.0 during Q4 2022, and registered a low of $486000.0 during Q4 2022.